Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab

American Journal of Hematology

Volumn 84, Issue 6, 2009, Pages 387-388

  Assayag, Franck ^a   Brousse, Nicole ^b   Couturier, Jérôme ^a   Macintyre, Elizabeth ^b   Mathiot, Claire ^a   Dewulf, Sébastien ^a   Froget, Benoît ^a   Vincent Salomon, Anne ^a   Decaudin, Didier ^a  

^a INSTITUT CURIE   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; RITUXIMAB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; LARGE CELL LYMPHOMA; LETTER; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOXYCYCLINE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICE; MICE, SCID; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 66849131580     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21415     Document Type: Letter

References (11)

1. Ferreri AJ, Ponzoni M, Guidoboni M, et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 2005;23:5067-5073. (Pubitemid 46224014)
2. Fife RS, Rougraff BT, Proctor C, Sledge GW Jr. Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells. J Lab Clin Med 1997;130:530-534. (Pubitemid 27526335)
3. Onoda T, Ono T, Dhar DK, et al. Doxycycline inhibits cell proliferation and invasive potential: Combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells. J Lab Clin Med 2004;143:207-216. (Pubitemid 38510116)
4. Fife RS, Sledge GW Jr, Sissons S, Zerler B. Effects of tetracyclines on angiogenesis in vitro. Cancer Lett 2000;153:75-78. (Pubitemid 30209846)
5. Richardson M, Wong D, Lacroix S, et al. Inhibition by doxycycline of angiogenesis in the chicken chorioallantoic membrane (CAM). Cancer Chemother Pharmacol 2005;56:1-9. (Pubitemid 41201749)
6. Iwasaki H, Inoue H, Mitsuke Y, et al. Doxycycline induces apoptosis by way of caspase-3 activation with inhibition of matrix metalloproteinase in human T-lymphoblastic leukaemia CCRF-CEM cells. J Lab Clin Med 2002;140:382-386. (Pubitemid 36017058)
7. Onoda T, Ono T, Dhar DK, et al. Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells. Int J Cancer 2006;118:1309-1315. (Pubitemid 43185622)
8. Chhipa RR, Singh S, Surve SV, et al. Doxycycline potentiates antitumor effect of cyclophosphamide in mice. Toxicol Appl Pharmacol 2005;202:268-277. (Pubitemid 40164280)
9. Hoyt JC, Ballering J, Numanami H, et al. Doxycycline modulates nitric oxide production in murine lung epithelial cells. J Immunol 2006;176:567-572. (Pubitemid 43023304)
10. Decaudin D, de Cremoux P, Vincent-Salomon A, et al. Ocular adnexal lymphoma: A review of clinicopathologic features and treatment options. Blood 2006;108:1451-1460. (Pubitemid 44316108)
11. Foroodi F, Duivenvoorden WC, Singh G. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells. Anticancer Drugs 2009;20:115-122.